நிக் போரிஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from நிக் போரிஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In நிக் போரிஸ் Today - Breaking & Trending Today
Forms integration to power Managed App users realestatebusiness.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from realestatebusiness.com.au Daily Mail and Mail on Sunday newspapers.
Managed App recognised as top real estate tech innovator realestatebusiness.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from realestatebusiness.com.au Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in . Celsion CORPFebruary 25, 2021 GMT Of 27 patients who completed interval debulking surgery, 80% of those treated with GEN-1 had an R0 resection compared with 58% of control patients, a 38% improvement To date 34 patients, or approximately one-third of the total, have been enrolled at 22 sites, including 20 patients in the treatment arm and 14 patients in the control arm LAWRENCEVILLE, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today provided an update on its Phase I/II OVATION 2 Study with GEN-1 in patients with advanced ovarian cancer, including interim observations. GEN-1 is Celsion’s DNA-mediated interleukin-12 (IL-12) immunotherapy designed u ....